David Roman

Stock Analyst at Goldman Sachs

(2.24)
# 2,822
Out of 5,043 analysts
52
Total ratings
46.67%
Success rate
-0.8%
Average return

Stocks Rated by David Roman

The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $72.85
Upside: -12.15%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $15.37
Upside: +4.10%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $75.68
Upside: +36.10%
iRhythm Technologies
Oct 1, 2025
Maintains: Neutral
Price Target: $158$180
Current: $182.71
Upside: -1.48%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57$64
Current: $68.50
Upside: -6.57%
Beta Bionics
Oct 1, 2025
Upgrades: Buy
Price Target: $18$26
Current: $23.75
Upside: +9.47%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $12.31
Upside: +62.47%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $13.45
Upside: +41.26%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $26.42
Upside: +9.77%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94$104
Current: $96.17
Upside: +8.14%
Initiates: Buy
Price Target: $380
Current: $325.80
Upside: +16.64%
Maintains: Neutral
Price Target: $120$104
Current: $103.12
Upside: +0.85%
Maintains: Buy
Price Target: $13$10
Current: $9.01
Upside: +10.99%
Maintains: Buy
Price Target: $94$82
Current: $78.35
Upside: +4.66%
Maintains: Neutral
Price Target: $24$23
Current: $27.07
Upside: -15.04%
Maintains: Buy
Price Target: $138$154
Current: $127.18
Upside: +21.09%
Maintains: Neutral
Price Target: $42$24
Current: $14.94
Upside: +60.64%
Maintains: Sell
Price Target: $63$71
Current: $71.98
Upside: -1.36%
Maintains: Buy
Price Target: $64$55
Current: $54.26
Upside: +1.36%
Reinstates: Buy
Price Target: $42
Current: $23.17
Upside: +81.27%
Maintains: Neutral
Price Target: $384$427
Current: $383.72
Upside: +11.28%
Maintains: Buy
Price Target: $81$90
Current: $80.82
Upside: +11.36%
Initiates: Buy
Price Target: $90
Current: $102.43
Upside: -12.14%
Initiates: Buy
Price Target: $500
Current: $551.25
Upside: -9.30%
Initiates: Buy
Price Target: $274
Current: $187.04
Upside: +46.49%
Initiates: Sell
Price Target: $83
Current: $94.13
Upside: -11.82%